Reappraisal of hMLH1 promoter methylation and protein expression status in the serrated neoplasia pathway

Histopathology

Volumn 69, Issue 2, 2016, Pages 198-210

  Lee, Eun Jung ^a   Chun, Sung Min ^b   Kim, Mi Jung ^a   Jang, Se Jin ^b   Kim, Do Sun ^a   Lee, Doo Han ^a   Youk, Eui Gon ^a  

^a Daehang Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

colon; dysplasia; hMLH1; hyperplastic polyp; sessile serrated adenoma

Indexed keywords

PROTEIN MLH1;

ADULT; AGED; ARTICLE; COLONOSCOPY; CONTROLLED STUDY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; POLYPECTOMY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; RECTUM ADENOMA;

EID: 84978208723     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12925     Document Type: Article

References (30)

1. Bateman AC, Shepherd NA. UK guidance for the pathological reporting of serrated lesions of the colorectum. J. Clin. Pathol. 2015; 68; 585–591.
2. O'Brien MJ, Zhao Q, Yang S. Colorectal serrated pathway cancers and precursors. Histopathology 2015; 66; 49–65.
3. Bosman FT, Carneiro F, Hruban RH, Theise ND. World Health Organization Classification of Tumours of the Digestive System. 4th ed. Lyon, France: IARC Press, 2010; 160–165.
4. Rex DK, Ahnen DJ, Baron JA et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am. J. Gastroenterol. 2012; 107; 1315–1329; quiz 1314, 1330.
5. Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am. J. Clin. Pathol. 2006; 125; 132–145.
6. Sheridan TB, Fenton H, Lewin MR et al. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions ‘caught in the act’. Am. J. Clin. Pathol. 2006; 126; 564–571.
7. Kim KM, Lee EJ, Ha S et al. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am. J. Surg. Pathol. 2011; 35; 1274–1286.
8. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am. J. Surg. Pathol. 2003; 27; 65–81.
9. Fujita K, Yamamoto H, Matsumoto T et al. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am. J. Surg. Pathol. 2011; 35; 295–304.
10. Hu H, Chang DT, Nikiforova MN, Kuan SF, Pai RK. Clinicopathologic features of synchronous colorectal carcinoma: a distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Am. J. Surg. Pathol. 2013; 37; 1660–1670.
11. Lu FI, van Niekerk de W, Owen D, Tha SP, Turbin DA, Webber DL. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am. J. Surg. Pathol. 2010; 34; 927–934.
12. IJspeert JE, Vermeulen L, Meijer GA, Dekker E. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications [Review]. Nat. Rev. Gastroenterol. Hepatol. 2015; 12; 401–409.
13. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum. Pathol. 2011; 42; 1–10.
14. García-Solano J, Conesa-Zamora P, Carbonell P et al. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas. Int. J. Cancer 2012; 131; 1790–1799.
15. Mäkinen MJ. Colorectal serrated adenocarcinoma [Review]. Histopathology 2007; 50; 131–150.
16. Gurzu S, Szentirmay Z, Toth E, Bara T, Bara T Jr, Jung I. Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition. PLoS ONE 2013; 8; e57699.
17. Burnett-Hartman AN, Newcomb PA, Potter JD et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res. 2013; 73; 2863–2872.
18. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT. Frequent CpG island methylation in serrated adenomas of the colorectum. Am. J. Pathol. 2003; 162; 815–822.
19. O'Brien MJ, Yang S, Mack C et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am. J. Surg. Pathol. 2006; 30; 1491–1501.
20. Kim YH, Kakar S, Cun L, Deng G, Kim YS. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int. J. Cancer 2008; 123; 2587–2593.
21. Sandmeier D, Benhattar J, Martin P, Bouzourene H. Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps. Histopathology 2009; 55; 206–213.
22. Ogino S, Kawasaki T, Brahmandam M et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J. Mol. Diagn. 2006; 8; 209–217.
23. Auclair J, Vaissière T, Desseigne F et al. Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles. Genes Chromosom. Cancer 2011; 50; 178–185.
24. Deng G, Chen A, Hong J, Chae HS, Kim YS. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 1999; 59; 2029–2033.
25. Capel E, Fléjou JF, Hamelin R. Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis. Oncogene 2007; 26; 7596–7600.
26. Kagara N, Huynh KT, Kuo C et al. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer. Am. J. Pathol. 2012; 181; 257–267.
27. Thompson RF, Suzuki M, Lau KW, Greally JM. A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry. Bioinformatics 2009; 25; 2164–2170.
28. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol. 2002; 160; 1823–1830.
29. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins [Review]. Virchows Arch. 2004; 445; 431–441.
30. Torlakovic EE, Gomez JD, Driman DK et al. Sessile serrated adenoma (SSA/P) vs. traditional serrated adenoma (TSA). Am. J. Surg. Pathol. 2008; 32; 21–29.